Literature DB >> 21623148

A comparative study of pre-operative imaging methods in patients with primary hyperparathyroidism: ultrasonography, 99mTc sestamibi, single photon emission computed tomography, and magnetic resonance imaging.

G Akbaba1, D Berker, S Isik, Y Aydin, D Ciliz, I Peksoy, U Ozuguz, Y A Tutuncu, S Guler.   

Abstract

AIM: This study compares the accuracy rates achieved in ultrasonography (US), 99mTc-sestamibi (MIBI), single photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI) as imaging methods used in the pre-operative localization of the enlarged parathyroid glands. SUBJECTS AND METHODS: For the purposes of this study, US, MIBI, SPECT, and MRI were performed on 98 patients with primary hyperparathyroidism (pHPT). All patients underwent parathyroidectomy.
RESULTS: Pre-operative localization of an abnormal parathyroid gland was successfully performed in 82 of the cases scanned with US (83.7%), while the result was 66 in the cases scanned with MIBI (67.3%), 71 of the cases were successfully localized with SPECT (72.4%), while MRI revealed the diseased gland in only 60 of the total cases (61.2%). In MIBI-positive and -negative patients there was a statistically significant difference among cases in terms of adenoma volume (1.30±1.51 vs 0.58±0.91, p<0.05). Sensitivity, specificity and diagnostic accuracy values were 87.2%, 25.0%, and 83.0%; 70.2%, 50.0%, and 69.4%; 75.5%, 50.0%, and 74.5%; 63.8%, 50.0%, and 63.3% for US, MIBI, SPECT, and MRI, respectively. The respective values for sensitivity, specificity, and diagnostic accuracy were 94.9%, 25.0%, and 91.1% when US was combined with MIBI.
CONCLUSIONS: Combining US and MIBI as imaging methods for pre-operative imaging of pHPT often produces more satisfactory results. While the accuracy of US is relatively low in the ectopic localizations, the size of the lesion can be an important factor in the accuracy achieved with MIBI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623148     DOI: 10.3275/7764

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  45 in total

1.  Pre-operative sestamibi-technetium subtraction scintigraphy in primary hyperparathyroidism: experience with 156 consecutive patients.

Authors:  J M Jones; C F Russell; W R Ferguson; J D Laird
Journal:  Clin Radiol       Date:  2001-07       Impact factor: 2.350

2.  Preoperative localization of parathyroid adenomas.

Authors:  Sofia Avitia; Ryan F Osborne
Journal:  Ear Nose Throat J       Date:  2009-04       Impact factor: 1.697

Review 3.  MR imaging of the thyroid and parathyroid glands.

Authors:  M B Gotway; C B Higgins
Journal:  Magn Reson Imaging Clin N Am       Date:  2000-02       Impact factor: 2.266

4.  Parathyroid glands: combination of (99m)Tc MIBI scintigraphy and US for demonstration of parathyroid glands and nodules.

Authors:  M L De Feo; S Colagrande; C Biagini; A Tonarelli; G Bisi; L Vaggelli; D Borrelli; P Cicchi; F Tonelli; A Amorosi; M Serio; M L Brandi
Journal:  Radiology       Date:  2000-02       Impact factor: 11.105

5.  Preoperative evaluation of patients with parathyroid adenoma: role of high-resolution ultrasonography.

Authors:  David Ulanovski; Raphael Feinmesser; Maya Cohen; Jaqueline Sulkes; Mickey Dudkiewicz; Thomas Shpitzer
Journal:  Head Neck       Date:  2002-01       Impact factor: 3.147

6.  Tc-99m MIBI parathyroid scintigraphy and intact parathyroid hormone levels in hyperparathyroidism.

Authors:  Guang-Uei Hung; Shyh-Jen Wang; Wan-Yu Lin
Journal:  Clin Nucl Med       Date:  2003-03       Impact factor: 7.794

7.  Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein.

Authors:  B K Mitchell; E A Cornelius; S Zoghbi; J R Murren; R Ghoussoub; S D Flynn; B K Kinder
Journal:  Surgery       Date:  1996-12       Impact factor: 3.982

8.  Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.

Authors:  William C Lavely; Sibyll Goetze; Kent P Friedman; Jeffrey P Leal; Zhe Zhang; Elizabeth Garret-Mayer; Alan P Dackiw; Ralph P Tufano; Martha A Zeiger; Harvey A Ziessman
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

9.  Beneficial effect of endocrinologist-performed ultrasonography on preoperative parathyroid adenoma localization.

Authors:  Baris Akinci; Tevfik Demir; Serkan Yener; Abdurrahman Comlekci; Omer Binicier; Ozhan Ozdogan; Mustafa Secil; Ali Sevinc; Mehmet Ali Kocdor; Firat Bayraktar; Tulay Canda; Sena Yesil
Journal:  Endocr Pract       Date:  2009 Jan-Feb       Impact factor: 3.443

10.  Localization of parathyroid adenomas by sonography and technetium tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidectomy: are both studies really needed?

Authors:  Mitchell E Tublin; Daniel A Pryma; John H Yim; Jennifer B Ogilvie; James M Mountz; Badreddine Bencherif; Sally E Carty
Journal:  J Ultrasound Med       Date:  2009-02       Impact factor: 2.153

View more
  8 in total

1.  Diagnostic value of endoscopic ultrasonography for preoperative localization of parathyroid adenomas.

Authors:  Reyhan Ersoy; Osman Ersoy; Berna Evranos Ogmen; Sefika Burcak Polat; Mehmet Kilic; Nilufer Yildirim; Levent Ozturk; Bekir Cakir
Journal:  Endocrine       Date:  2014-01-11       Impact factor: 3.633

2.  Preoperative localization of parathyroid lesion: diagnostic usefulness of color doppler ultrasonography.

Authors:  Afshin Mohammadi; Farzad Moloudi; Mohammad Ghasemi-Rad
Journal:  Int J Clin Exp Med       Date:  2012-01-15

3.  Successful minimally invasive surgery for primary hyperparathyroidism: influence of preoperative imaging and intraoperative parathyroid hormone levels.

Authors:  Gaëtan-Romain Joliat; Nicolas Demartines; Luc Portmann; Ariane Boubaker; Maurice Matter
Journal:  Langenbecks Arch Surg       Date:  2015-11-21       Impact factor: 3.445

4.  Application of carbon nanoparticles for parathyroid protection in reoperation of thyroid diseases.

Authors:  Bo Gao; Wuguo Tian; Yan Jiang; Shu Zhang; Lingji Guo; Jianjie Zhao; Gang Zhang; Shuai Hao; Yan Xu; Donglin Luo
Journal:  Int J Clin Exp Med       Date:  2015-12-15

5.  Overt metabolic bone failure as the initial manifestation of neglected primary hyperparathyroidism: An unusual presentation and review of current practice guidelines.

Authors:  Narendran Pushpasekaran; Gokuldev Vasudevan; Veliyaveettil Muhamed Khaleel; Antony Sebastain; Saubhik Das
Journal:  J Clin Orthop Trauma       Date:  2020-01-22

6.  A retrospective analysis of the diagnostic performance of 11C-choline PET/CT for detection of hyperfunctioning parathyroid glands after prior negative or discordant imaging in primary hyperparathyroidism.

Authors:  M E Noltes; S Kruijff; L Jansen; H E Westerlaan; W T Zandee; R A J O Dierckx; A H Brouwers
Journal:  EJNMMI Res       Date:  2021-03-26       Impact factor: 3.138

7.  Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.

Authors:  Elske Quak; Audrey Lasne Cardon; Renaud Ciappuccini; Charline Lasnon; Vianney Bastit; Véronique Le Henaff; Barbara Lireux; Gauthier Foucras; Cyril Jaudet; Celia Berchi; Jean-Michel Grellard; Justine Lequesne; Bénédicte Clarisse; Stéphane Bardet
Journal:  BMC Endocr Disord       Date:  2021-01-07       Impact factor: 2.763

8.  3-phase dual-energy CT scan as a feasible salvage imaging modality for the identification of non-localizing parathyroid adenomas: a prospective study.

Authors:  Michael Roskies; Xiaoyang Liu; Michael P Hier; Richard J Payne; Alex Mlynarek; Veronique Forest; Mark Levental; Reza Forghani
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.